Skip to main content
. 2017 Feb;113(Pt A):206–216. doi: 10.1016/j.neuropharm.2016.10.013

Table 2.

Fit parameters of concentration- and dose-response relationships for To042 and mexiletine for antimyotonic activity in vitro and in vivo.

In vitro
In vivo
IC50 (μM) nH ED50 (mg/kg) nH Min (%)
To042 0.14 ± 0.02 0.9 ± 0.1 0.07 ± 0.02 1.2 ± 0.3 30.9 ± 4.4
Mexiletine 16.9 ± 2.4 1.2 ± 0.2 7.0 ± 0.02 1.2 ± 0.2 18.0 ± 7.3

Parameter values were determined from the fit of concentration– and dose-response relationships shown in Fig. 4, Fig. 5 with standard Hill equations (1), (2), respectively. The values are given together with the SE of the fit.